A researcher in 2026 must choose: work on native peptides (ease of SPPS synthesis, abundant literature) or optimised mimetics (better pharmacokinetics, but complex synthesis, less literature)
Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)
The study used 0.5 mg/kg oral KPV doses and documented significant NF-B suppression in colonic tissue
That means big pharma can't make money off BPC-157, and that means it's not getting marketed to your local doctor or hospital or anywhere else in the health care system
Because BPC-157 is stable gastrically, it can be taken with or without food once a day
Depending on your evaluation and lab results, same-day treatment may be available at our Manteca clinic